SOD1 inhibition enhances sorafenib efficacy in HBV‐related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS‐mediated cell death

Jooyoung Lee(Ulsan College), Sung‐Gyu Lee(Dankook University)
Journal of Cellular and Molecular Medicine
July 1, 2024
Cited by 7


Related Papers